{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:48Z","timestamp":1707524748993},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"DOI":"10.7759\/cureus.29742","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T13:44:56Z","timestamp":1664459096000},"source":"Crossref","is-referenced-by-count":0,"title":["Granulomatosis With Polyangiitis in Untreated Graves\u2019 Disease: A Rare Event"],"prefix":"10.7759","author":[{"given":"Syed Ahmad","family":"Moosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuleyka","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Mariano","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameera","family":"Ishtiaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves' disease","volume":"358","author":"Brent GA","year":"2008","unstructured":"Brent GA. Clinical practice. Graves' disease. N Engl J Med. 2008, 358:2594-2605. 10.1056\/NEJMcp0801880","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80045-0","article-title":"Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease","volume":"28","author":"Pillinger M","year":"1998","unstructured":"Pillinger M, Staud R.. Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease. Semin Arthritis Rheum. 1998, 28:124-129. 10.1016\/S0049-0172(98)80045-0","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone JH","year":"2003","unstructured":"Stone JH. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003, 48:2299-2309. 10.1002\/art.11075","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.595","article-title":"Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease","volume":"10","author":"Sera N","year":"2000","unstructured":"Sera N, Ashizawa K, Ando T, et al.. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid. 2000, 10:595-599. 10.1089\/thy.2000.10.595","journal-title":"Thyroid"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021383","article-title":"Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole","volume":"88","author":"Gum\u00e0 M","year":"2003","unstructured":"Gum\u00e0 M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Oliv\u00e9 A. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol Metab. 2003, 88:2141-2146. 10.1210\/jc.2002-021383","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-03207","article-title":"Optic neuropathy secondary to granulomatosis with polyangiitis in a patient with Graves\u2019 disease: a case report","volume":"15","author":"Sato-Akushichi M","year":"2021","unstructured":"Sato-Akushichi M, Kinouchi R, Kawai N, et al.. Optic neuropathy secondary to granulomatosis with polyangiitis in a patient with Graves\u2019 disease: a case report. J Med Case Rep. 2021, 15:618. 10.1186\/s13256-021-03207","journal-title":"J Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis: thyroid storm","volume":"22","author":"Burch HB","year":"1993","unstructured":"Burch HB, Wartofsky L.. Life-threatening thyrotoxicosis: thyroid storm. Endocrinol Metab Clin North Am. 1993, 22:263-277. 10.1016\/S0889-8529(18)30165-8","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91920-2","article-title":"Thyroid-stimulating antibody in Graves' disease","volume":"323","author":"Davies","year":"1984","unstructured":"Davies, TF. . Thyroid-stimulating antibody in Graves' disease. Lancet. 1984, 323:1417-1418. 10.1016\/S0140-6736(84)91920-2","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-28-11-1623","article-title":"Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis","volume":"28","author":"Wyse EP","year":"1968","unstructured":"Wyse EP, McConahey WM, Woolner LB, Scholz DA, Kearns TP. Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1968, 28:1623-1629. 10.1210\/jcem-28-11-1623","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2804","article-title":"Prolonged duration of Hashitoxicosis in a patient with Hashimoto's thyroiditis: a case report and review of literature","volume":"10","author":"Shahbaz A","year":"2018","unstructured":"Shahbaz A, Aziz K, Umair M, Sachmechi I. Prolonged duration of Hashitoxicosis in a patient with Hashimoto's thyroiditis: a case report and review of literature. Cureus. 2018, 10:e2804. 10.7759\/cureus.2804","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo S","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016, 388:906-918. 10.1016\/S0140-6736(16)00278-6","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn DM","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, et al.. Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017, 64:e1-e33. 10.1093\/cid\/ciw694","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048338","article-title":"The spectrum of Wegener's granulomatosis and disease relapse","volume":"352","author":"Bacon PA","year":"2005","unstructured":"Bacon PA. The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med. 2005, 352:330-332. 10.1056\/NEJMp048338","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-012-0238-6","article-title":"Granulomatosis with polyangiitis in childhood","volume":"14","author":"Twilt M","year":"2012","unstructured":"Twilt M, Benseler S, Cabral D. Granulomatosis with polyangiitis in childhood. Curr Rheumatol Rep. 2012, 14:107-115. 10.1007\/s11926-012-0238-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(54)90255-7","article-title":"Wegener's granulomatosis","volume":"17","author":"Fahey JL","year":"1954","unstructured":"Fahey JL, Leonard E, Churg J, et al.. Wegener's granulomatosis. Am J Med. 1954, 17:168-179. 10.1016\/0002-9343(54)90255-7","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2010.04.003","article-title":"Microscopic polyangiitis","volume":"36","author":"Chung SA","year":"2010","unstructured":"Chung SA, Seo P. Microscopic polyangiitis. Rheum Dis Clin North Am. 2010, 36:545-558. 10.1016\/j.rdc.2010.04.003","journal-title":"Rheum Dis Clin North Am"},{"key":"ref17","article-title":"Churg Strauss Syndrome","author":"Chakraborty RK","year":"2022","unstructured":"Chakraborty RK, Aeddula NR. Churg Strauss Syndrome. StatPearls [Internet], Treasure Island, FL, USA; 2022."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino G","year":"2013","unstructured":"Barbesino G, Tomer Y. Clinical review: clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab. 2013, 98:2247-2255. 10.1210\/jc.2012-4309","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/1050725041517011","article-title":"High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves' disease and silent thyroiditis","volume":"14","author":"Hiraiwa T","year":"2004","unstructured":"Hiraiwa T, Ito M, Imagawa A, et al.. High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves' disease and silent thyroiditis. Thyroid. 2004, 14:531-535. 10.1089\/1050725041517011","journal-title":"Thyroid"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.08.016","article-title":"ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis","volume":"120","author":"Finkielman JD","year":"2007","unstructured":"Finkielman JD, Lee AS, Hummel AM, et al.. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007, 120:643.e9-643.e14. 10.1016\/j.amjmed.2006.08.016","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching AR","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, et al.. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020, 6:71. 10.1038\/s41572-020-0204-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2017.71638","article-title":"The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis","volume":"55","author":"Masiak A","year":"2017","unstructured":"Masiak A, Zdrojewski Z, P\u0119ksa R, et al.. The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Reumatologia. 2017, 55:230-236. 10.5114\/reum.2017.71638","journal-title":"Reumatologia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-13421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021, 73:1366-1383. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-232. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar C","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, et al.. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009, 68:310-317. 10.1136\/ard.2008.088096","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114986-granulomatosis-with-polyangiitis-in-untreated-graves-disease-a-rare-event","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:15Z","timestamp":1707507615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114986-granulomatosis-with-polyangiitis-in-untreated-graves-disease-a-rare-event"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.29742","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}